Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...
Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025 Ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback